Nordic Life Science 1
PHOTO KAUTE FOUNDATIONKENNET RUONA PHOTO HANS CHR
ISTIAN PEDERSEN Prateek Singh, founder and CEO, Finnadvance Pål Rongved, CEO/CSO, AdjuTec Pharma 05 Gulli Arnason, CMCO, Sidekick Health Patrik Dahlen, CEO, Immunovia Finnish start-up Finnadvance’s platform can speed up drug and vaccine development, and reduce the need for animal studies. Norwegian start-up company AdjuTec’s novel antibiotic resistance breakers may retain efficacy and facilitate reduced use of antibiotics. ISD Immunotech expects to finalize characterization of its lead candidate this year, and develop the first personalized treatment for severe lupus. Sidekick aims to reduce healthcare strain and nudge people towards lasting lifestyle and behavior changes with its digital therapeutics innovations. Diagnostic company Immunovia is now extremely close to market launch and the first order for its early pancreatic cancer detection test.